Serial #79403607
LIVE

Serial Number

79403607

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79403607 Trademark

Serial Number: 79403607

Serial #79403607 is a trademark filed by NOVARTIS AG on April 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

NOVARTIS AG (7,170 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 22, 2024

Registration Date

Not Registered

Published for Opposition

April 28, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Apr 23, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 8, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 8, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2026 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 19, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 4, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 4, 2026 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 8, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 7, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 5, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Nov 13, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 7, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 6, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 19, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 19, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 19, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 19, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 19, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Sep 17, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 12, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 5, 2024 REPR